The pharmaceutical landscape for blood sugar is shifting, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this approach offers a more convenient way to https://albiedxdu644660.gynoblog.com/39763296/glp-1-patches-a-innovative-approach-to-blood-sugar-treatment